Correlation Between Iovance Biotherapeutics and Viracta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Viracta Therapeutics, you can compare the effects of market volatilities on Iovance Biotherapeutics and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Viracta Therapeutics.
Diversification Opportunities for Iovance Biotherapeutics and Viracta Therapeutics
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Iovance and Viracta is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Viracta Therapeutics go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Viracta Therapeutics
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 0.89 times more return on investment than Viracta Therapeutics. However, Iovance Biotherapeutics is 1.13 times less risky than Viracta Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Viracta Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 549.00 in Iovance Biotherapeutics on September 14, 2024 and sell it today you would earn a total of 227.00 from holding Iovance Biotherapeutics or generate 41.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. Viracta Therapeutics
Performance |
| Timeline |
| Iovance Biotherapeutics |
| Viracta Therapeutics |
Iovance Biotherapeutics and Viracta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and Viracta Therapeutics
The main advantage of trading using opposite Iovance Biotherapeutics and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| Viracta Therapeutics vs. Puma Biotechnology | Viracta Therapeutics vs. Iovance Biotherapeutics | Viracta Therapeutics vs. Day One Biopharmaceuticals | Viracta Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |